| 标题 |
 Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet Respiratory Medicine 作者：Yi‐Long Wu; Ying Cheng; Jianying Zhou; Shun Lü; Yiping Zhang; et al 出版日期：2020-05-29 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
张欢馨
Nole
yjh123
东方元语
cdercder
xing_xing
行走的荷尔蒙
1104481279
OK
科研狗
Kao
woshi123
ddd
huang
aajhajkahna
天晴
Criminology34
殷勤的紫槐
渡人舟
ming2026
皖公网安备34019202002308
